Casi Pharmaceuticals Inc (CASI)
Market Open
17 Mar, 13:30
NASDAQ (CM) NASDAQ (CM) Primary 
XFRA $
0. 15
+0
+3.0822%
$
2.33M Market Cap
- P/E Ratio
- Div Yield
7,897 Volume
0 Eps
$ 0.15
Previous Close Want to track CASI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Casi Pharmaceuticals Inc (CASI) Statistics
Valuation metrics
Market Cap 2.33M
Enterprise value 16.5M
Trailing P/E (ttm) -0.07
Forward P/E -
PEG ratio 0
Price/Sales (ttm) 0.17
Price/Book (mrq) -0.08
Enterprise Value/Revenue 1.22
Enterprise Value/EBITDA -0.54
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) -
Average volume (90 days) 2.97K
Price summary
52-Week low 0.14
52-Week high 3.09
Beta -
50-Day moving average -
200-Day moving average 0.48
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:10
Last split Date 2 Jun 2022
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -2.6%
Operating margin -2.39%
Operational effectiveness
Return on assets -1.43%
Return on equity 1.84%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.84
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.18
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.29
Total debt (mrq) -
Total Debt/Equity (mrq) -0.66
Current ratio (mrq) 0.3%
Book value per share (mrq) -1.78
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
